SOLVITA Trademark

Trademark Overview


On Wednesday, January 10, 2024, a trademark application was filed for SOLVITA with the United States Patent and Trademark Office. The USPTO has given the SOLVITA trademark a serial number of 98350232. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 13, 2024. This trademark is owned by Community Blood Center. The SOLVITA trademark is filed in the Pharmaceutical Products category with the following description:

Allograft material, namely, processed human bone and tissue for use in surgical or medical procedures; Allograft material, namely, human bone and tissue processed into implants, scaffolds, powders, gels, pastes, putty, mats, films, strips, sheets, molded pieces, surgical patches, plugs, wound dressings, or wound coverings; Growth factor proteins, namely, proteins for promoting tissue growth and repair, processed into surgical implants, scaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Allograft material, namely, soft tissue implant for use in surgery; Bone void fillers consisting of biological materials...

General Information


Serial Number98350232
Word MarkSOLVITA
Filing DateWednesday, January 10, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, November 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesAllograft material, namely, processed human bone and tissue for use in surgical or medical procedures; Allograft material, namely, human bone and tissue processed into implants, scaffolds, powders, gels, pastes, putty, mats, films, strips, sheets, molded pieces, surgical patches, plugs, wound dressings, or wound coverings; Growth factor proteins, namely, proteins for promoting tissue growth and repair, processed into surgical implants, scaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Allograft material, namely, soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and bone

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCommunity Blood Center
Party Type10 - Original Applicant
Legal Entity Type54 - NOT AVAILABLE
AddressDayton, OH 45402

Trademark Events


Event DateEvent Description
Wednesday, January 10, 2024NEW APPLICATION ENTERED
Monday, April 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 2, 2024ASSIGNED TO EXAMINER
Friday, August 9, 2024NON-FINAL ACTION E-MAILED
Friday, August 9, 2024NON-FINAL ACTION WRITTEN
Friday, August 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, November 7, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, November 7, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 7, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER